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Malaria prevention strategies
L. Von Seidlein
Mahidol Oxford Tropical Medicine Research Unit,
Bangkok, Thailand
Abstract: Substantial gains have been made in the control of
malaria; in many regions malaria has reached historically low
prevalence. Still the global malaria burden remains unacceptably
high and the spread of antimalarial and insecticide resistance
threatens a resurgence.
A number of malaria prevention strategies have been evaluated
since the turn of the century. Intermittent presumptive therapy
(IPT) held initially great promise but has ultimately disappointed
and has not been implemented. Seasonal malaria chemoprophy-
laxis has evolved from IPT and restricts presumptive therapy to the
months with the highest malaria incidence. This strategy is ﬁnd-
ing increasing acceptance. Malaria vaccines have a long history but
have yet to result in the roll-out of a safe, highly protective, long
lasting product. The last candidate, RTS,S/AS01 held great hope but
also has ultimately disappointed and the inclusion in the expanded
program of immunisations has not been recommended at the end
of last year. There are new vaccine candidates on the horizon but
there is no reasonable hope that a vaccine can be used to prevent
malaria on a population level in the near future.
The ultimate hope to prevent malaria has to be the elimination
of malaria. While considered unrealistic until recently a range of
novel strategies aim now at the elimination of malaria.
http://dx.doi.org/10.1016/j.ijid.2016.02.069
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Management of relapsing Plasmodium vivax
malaria
C. Chu
Bangkok, Thailand
Abstract: Plasmodium vivax (P.vivax) endemicity covers large
and diverse geographical regions. Transmission is lower than
Plasmodium falciparum, however, relapses caused by hypnozoite
forms increase the number of infections and sustain transmission.
Resistance against chloroquine is increasing and assessment of
efﬁcacy is confounded because recrudescence, relapse and rein-
fection cannot be distinguished reliably. Background incidence
of new P.vivax infections are needed for comparing efﬁcacy of
treatment regimens. Primaquine is the only currently widely avail-
able treatment effective against relapses (hypnozoite stage) of
P.vivax and assessment of its radical curative efﬁcacy using cur-
rently recommended dosing is required. Optimising primaquine
regimens may be necessary to improve adherence in some pop-
ulations. The assurance of primaquine safety in persons with
glucose-6-phosphate-dehydrogenase (G6PD) deﬁciency is essen-
tial if deployed universally for malaria elimination.
Methods: BetweenMarch 2010 and July 2015 a series of studies
were conducted in northwestern Thailand along the Myanmar
border. In the ﬁrst study, a rolling cohort of 200 healthy subjects
with a history of P.vivax were given primaquine for radical cure
and followed until a new P.vivax infection. The overall incidence
of new P.vivax infection was 0.13 infections per person-year. In a
parallel study 650 subjects with P.vivax malaria were randomized
to artesunate, chloroquine or chloroquine+primaquine (only G6PD
normal subjects) and followed for one year. At least one recurrence
with P.vivax occurred in over 70% subjects in non-primaquine
arms and in 18% subjects taking primaquine. The burden of
relapse was calculated to be 78%. In a third study, 680 G6PD nor-
mal subjects were randomized to chloroquine+primaquine
7 days (1mg/kg/day), chloroquine+primaquine 14 days
(0.5mg/kg/day), dihydroartemisinin-piperaquine+primaquine 7
days or dihydroartemisinin-piperaquine+primaquine 14 days.
Recurrences within one year follow up with P.vivax were
treated with a standard dose of chloroquine+primaquine 14
days (0.5mg/kg/day). Subjects with at least one recurrence were
not signiﬁcantly different between the 7 and 14-day primaquine
regimens, although non-inferiority of the 7-day regimen was
inconclusive.
Conclusion: Relapse contributes substantially to the burden of
P.vivax malaria. High dose primaquine (7mg/kg) over 7 or 14-days
are efﬁcacious and universal deployment is likely necessary for
P.vivax elimination. However, safety of these regimens in persons
with G6PD deﬁciency requires conﬁrmation.
http://dx.doi.org/10.1016/j.ijid.2016.02.070
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Epidemiology and ecology of rickettsial
infections
R. Premaratna
University of Kelaniya, Faculty of Medicine, Ragama,
Sri Lanka
Abstract: Rickettsiae are obligatory intracellular bacteria, trans-
mitted to vertebrates by arthropod vectors, primarily by ﬂeas
and ticks. A rapid increase in the incidence of four endemic rick-
ettsioses; Rocky Mountain spotted fever, Mediterranean spotted
fever, North Asian tick typhus, and Queensland tick typhus was
noted since 1970s and for Japanese spotted fever, since its discov-
ery in mid-1980s. As a result, spotted fever group of rickettsiae
(SFG) currently include over 25 formally recognized species. Ele-
vated attention to rickettsial diseases, advent and adaptation of
new molecular tools used for ﬁeld and laboratory studies in the
1990s and increase in funding support have lead to this second pro-
nounced increase in the discovery of novel species and the increase
in incidence of tick-borne rickettsial diseases in the last 40 years.
Change in ecological factors which determine the vector species
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and their behaviour, particularly those driven by climate change or
humanactivities suchasdeforestation,humanbehavioural changes
such as recreative activities that involve close association with
nature, human population increases and the improvements in
surveillance methodologies may contribute to the change in rick-
ettsial diseaseecologyandepidemiology. Since theuseofmolecular
technologies, numerous rickettsiae from kown to unknown or
variable degrees of pathogenicity for humans are being found to
co-circulate in overlapping geographic regions and demonstrated
in the same tick species. Furthermore, the discovery and descrip-
tion of novel nosological entities caused by previously unknown
SFG rickettsiae, ability ofmost rickettsiae to circulate in diverse syl-
vatic or peridomestic reservoirs without having obvious impacts
on their vertebrate hosts or affecting humans, occurance of rick-
ettsiae in association with a wide range of hard and soft ticks
which feed on very different species of large and small animals,
their mmaintenance in these vector systems by both vertical and
horizontal transmission has lead to a degree where the tradi-
tional views of tick-borne rickettsioses as endemic diseases with
largely focal distributions, limited host and geographic ranges, pre-
determined seasonality and deﬁned tick associations to become
obsolete or at least very incomplete. Therefore, continuous vigi-
lance, survailance, research and funding are warranted in order to
understand the changing ecology and epidemiology of rickettsial
diseases.
http://dx.doi.org/10.1016/j.ijid.2016.02.071
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Challenges and opportunities in the diagnosis
and management of rickettsial infections in
Southeast Asia
G.M. Varghese
Christian Medical College, Vellore, India
Abstract: Rickettsial infections are increasing in all regions of
Southeast Asia where sought. Given the non-speciﬁc presenting
symptoms resembling those of other endemic infections, diagno-
sis can be challenging, even to the most experienced clinician.
Available tests have limitations, with no good gold standard diag-
nostic test. Serological tests are the mainstay of diagnosis with the
IgM indirect immunoﬂuorescence assay being the reference test.
However, the enzyme-linked immuno-sorbent assay is used more
commonly due to the ease of performance and a good sensitiv-
ity and speciﬁcity. Paired samples, obtained at least two weeks
apart, demonstrating a minimum 4 fold titre rise, are needed for
improved serologic speciﬁcity, limiting its clinical feasibility. Other
methods of testing have become available, but at this time, these
remain insufﬁcient to provide the rapid point-of-care diagnostics
that would be necessary to signiﬁcantly change the management
of this infection by providers in endemic areas. The mainstay of
treatment is Doxycycline although the intravenous formulations
are unavailable in several countries. Macrolides have proven efﬁ-
cacy inmild cases and intravenous Azithromycin is used alongwith
oral Doxycycline in seriously ill with suboptimal gastrointestinal
absorption and bioavailability. This presentation reviews the chal-
lenges in the laboratory diagnosis and management of rickettsial
infections unique to Southeast Asia, and examines data on emerg-
ing resistance to antimicrobial drugs.
http://dx.doi.org/10.1016/j.ijid.2016.02.072
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Current understanding of scrub typhus
immunity and vaccine development: the way
ahead
D.H. Walker
The University of Texas Medical Branch, Galveston,
TX, USA
Abstract: An effective vaccine against scrub typhus is needed
because of the high incidence (1 million cases annually is likely an
underestimate), large geographic distribution in Asia and islands of
the Indian and Paciﬁc oceans, difﬁculty of diagnosis at the time of
presentation as undifferentiated febrile illness, lack of an effective
low-cost point-of-care diagnostic method to be deployed in rural
areas, case fatality rate of 7-10%, and natural resistance to many
commonly used antibiotics.
Scientiﬁc obstacles to development of a vaccine include great
antigenic diversity of the immunodominant 56 kDa surface protein
antigen that has four major variable domains; weak, short-lived
cross protection against the numerous heterologous strains; loss
of protection against even the homologous strain after a few years;
and poor knowledge of the mechanisms of immune protection,
which are mostly based on studies in an invalid animal model.
Current knowledge indicates that the target cells of intracel-
lular Orientia tsutsugamushi are dendritic cells and macrophages in
themite feeding inoculation lesion (eschar) andmainly endothelial
cells, and secondarily,macrophages in the full-blowndisseminated
infection. Studies in a valid disseminated endothelial cell target
model indicate that CD8 T lymphocytes play an important role.
Earlier studies using the invalid peritoneal infection model suggest
that antibodies to the 56 kDa protein provide protection against
only the homologous strain, cross protection is T cell dependent,
and gamma interferon likely plays an important role. The 47 kDa
and ScaA proteins, which are conserved among strains, stimulate
partial protection.
The critical gaps in knowledge include determining the basis
for insufﬁcient immunological memory triggered by natural infec-
tion, deﬁning the contributions of T lymphocyte subsets, NK cells,
dendritic cells, and various cytokines and chemokines to vaccine-
induced immunity, the orientiacidal mechanisms particularly in
infected endothelial cells, and the prevalence, mechanisms, and
consequences of persistent Orientia infection.
The approach toward vaccine development should utilize the
valid disseminated endothelial cell infection model, bioinformat-
ics identiﬁcationofpotential conservedvaccineantigens, especially
subdominant surface and secreted proteins, and determination of
which novel adjuvants enhance long-lived protective memory T
and B cells. The goal is to do better than nature by stimulating
sterilizing, sustained cross-protection against all strains of O. tsut-
sugamushi.
http://dx.doi.org/10.1016/j.ijid.2016.02.073
